Tag: Europe
-
Infographic – Vaccinations Changed the World
This chart, courtesy of Der Spiegel and Statista, shows how the incidence of several diseases has been reduced in the U.S. since the introduction of vaccines.
-
AstraZeneca, Biotech Partner on Messenger RNA Therapies
Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments.
-
3-D Printing Process Developed for Living Tissue
Researchers in the U.K. devised 3-D printing techniques for human and animal cells to produce functioning tissue with multiple types of cells.
-
Parkinson’s Protein Experiment in Space Station Cargo
An experiment to grow a crystallized form of protein associated with Parkinson’s disease is among the cargo that lifted off today from NASA’s Kennedy Space Center.
-
Patent Set for Peptide Nerve Damage Treatments
The European Patent Office announced its intent to award a patent on treatments for nerve cell damage based on the peptide thymosin beta 4.
-
Viruses Removed from Pig Organs for Human Transplants
Researchers in the U.S., Denmark, and China devised a process with genome editing to remove viruses that prevent organs from pigs from being used for human transplants.
-
Peptide Immunotherapy Shown Safe for Type 1 Diabetes
In an early clinical trial, researchers in the U.K. show treatments with peptides, fragments of proteins, are safe and can slow the progression of type 1 diabetes.
-
Study Underway of Depression, Bipolar Disorder Genetics
A large-scale study by two companies and a think tank started enrolling participants to learn more about the role of genetics in major depressive and bipolar disorders.
-
University, Company Employ AI for Anti-Aging Drugs
The medical analytics company Insilico Medicine is partnering with a university in Denmark to apply artificial intelligence to find new treatments for diseases associated with early aging.
-
RNA Vaccine for Rabies Found Safe, Generates Antibodies
A vaccine to prevent rabies made from messenger RNA, genetic material transcribed from DNA, was shown in a clinical trial to be generally safe and able under some conditions to induce antibodies.